Dr. Barbaro’s work seeks to improve the short- and long-term outcomes for children requiring life support technologies. His research has focused on the life support technology known as extracorporeal membrane oxygenation (ECMO), which provides pulmonary or cardiac life support when mechanical ventilation and medical management fails. Dr. Barbaro and co-investigators are also leading an international NIH-funded study called ASCEND (ARDS in Children and ECMO initiation strategies’ impact on Neuro-Development). ASCEND aims to characterize the one-year outcomes of ECMO-supported children and aims to address the question of if and when ECMO should be initiated in children with severe lung injury called pediatric acute respiratory distress syndrome. Dr. Barbaro is also the Registry Chair for the Extracorporeal Life Support Organization (ELSO), an international consortium of more than 500 ECMO centers, and is a Training to Advance Care Through Implementation Science in Cardiac And Lung Illnesses (TACTICAL) Scholar. Additional research will focus on encouraging the implementation of evidenced-based processes of care.
- M.D., University of North Carolina
- M.S., Health and Health Care Research, University of Michigan
- B.S., University of North Carolina